Document is current
Any future updates will be listed below
-
Authors
Raju, S. Vamsee
Rasmussen, Lawrence
Sloane, Peter A.
Tang, Li Ping
Libby, Emily Falk
Rowe, Steven M. https://orcid.org/0000-0001-9045-0133
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (DK072482)
National Institutes of Health (R01HL105487)
Cystic Fibrosis Foundation (R464-CR11)
AstraZeneca (DAL-IT-11)
American Lung Association (RG-305752)
Flight Attendant Medical Research Institute (YFA13008)
- License Information
-
More Information
Article History
Received: 12 August 2017
Accepted: 12 September 2017
First Online: 18 September 2017
Ethics approval
: All animal protocols were reviewed and approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee.
: Not applicable.
: SMR has received COPD-related grant funding from NHLBI and the Forest Research Institute. SMR has also received grant funding and consulting income from Vertex Pharmaceuticals for the design and conduct of CF clinical trials. SVR has received funding from Celgene for CF research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
